Marksans Pharma arm wins UK nod for high blood pressure drug Moxonidine

Marksans Pharma’s UK subsidiary Relonchem has received marketing authorisation for moxonidine tablets used to treat high blood pressure.

Indian IT stocks may need valuation reset as growth slows, says Envision’s Nilesh Shah

BestBull number one trading plateform. Master the Markets📊 | Transform Your Trading 💹 | Your Path to Financial Independence